IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours

Amary, M Fernanda, Bacsi, Krisztian, Maggiani, Francesca, Damato, Stephen, Halai, Dina, Berisha, Fitim, Pollock, Robin, O'Donnell, Paul +8 more·2011·The Journal of Pathology

Cited by (1,000)

Items 701–800 of 1,000

  1. Spinal sarcomas and immunity: An undervalued relationship
    Charbel K. Moussalem, Elie Massaad, Wassim Baassiri, M. Akhtar Anwar, Firas H. Kobeissy, Ali Hussein Eid, Nadine Darwiche, Ibrahim A. Omeis · 2019 · Seminars in Cancer Biology
  2. Quantitative Analysis of Oncometabolite 2-Hydroxyglutarate
    Bi‐Feng Yuan · 2021 · Advances in experimental medicine and biology
  3. Lessons from the deep study of rare tumours
    David Morgan Thomas · 2011 · The Journal of Pathology
  4. An Integrated Clinical Genomic and Transcriptomic Subgrouping of Central Chondrosarcoma
    Debora M. Meijer, Sanne Venneker, Baptiste Ameline, Zeynep Erdem, Sara Cardoso, Dina Ruano, Inge H. Briaire‐de Bruijn, Brendy E. van den Akker, Pauline M. Wijers‐Koster, Claire H J Scholte et al. · 2025 · Modern Pathology
  5. Integrative machine learning-guided in silico and in vitro approach reveals selective small molecule inhibitors targeting mutant IDH1
    Mayank Bajaj, Rohit Kumar, Vishal Pandey, Sahanawaz Parvez, Hemanth Kumar Tanneru, Polamarasetty Aparoy, Roy Karnati · 2025 · RSC Advances
  6. Nanomedicines: an update of diagnostic and therapeutic applications in multiple cancers
    Sani Jaysing Shinde, Priyanka, Manju Jakhar, Isha Arora, Deepika Sehgal, Mahak, Anupama Kumari, Tamanna Dhiman, Priya, Narender Kumar et al. · 2026 · Journal of drug targeting
  7. Integrated Molecular and Histological Insights for Targeted Therapies in Mesenchymal Sinonasal Tract Tumors
    Cosima C. Hoch, Leonard Knoedler, Samuel A. Knoedler, Ali Bashiri Dezfouli, Benedikt Schmidl, Anskar Trill, Jennifer E. Douglas, Nithin D. Adappa, Fabian Stögbauer, Barbara Wollenberg · 2024 · Current Oncology Reports
  8. Advancing the Management of Skull Base Chondrosarcomas: A Systematic Review of Targeted Therapies
    Edoardo Agosti, Marco Zeppieri, Sara Antonietti, Tamara Ius, Marco Maria Fontanella, Pier Paolo Panciani · 2024 · Journal of Personalized Medicine
  9. IDH Mutations in Chondrosarcoma Correlate with Patient Survival in De-Differentiated but Not Conventional Subtypes
    Jay Swayambunathan, Paula Viza Gomes, Robert V. Childers, Nicole L. Levine, Julia D. Visgauss · 2025 · Journal of Clinical Medicine
  10. From Inhibitors to PET: SAR-Based Development of [18F]SK60 for mIDH1 Imaging
    Sarandeep Kaur, Sladjana Dukic-Stefanovic, Winnie Deuther‐Conrad, Magali Toussaint, Barbara Wenzel, Peter Lönnecke, Cornelius Kurt Donat, Rareş‐Petru Moldovan, Klaus Kopka · 2025 · Journal of Medicinal Chemistry
  11. Molecular genetics of chondroid tumours
    Carlos E. de Andrea, Pancras C.W. Hogendoorn · 2014 · Diagnostic histopathology
  12. Solid-papillary carcinoma with reverse polarity (SPCRP) harboring a novel IDH1 R132C mutation: A case confirming the expected IDH1/IDH2 dichotomy
    Paul S. Weisman, Qiqi Yu, Christopher M. Flynn, William M. Rehrauer, Jin Yan Xu · 2020 · Human Pathology Case Reports
  13. Update of Key Clinical, Histological and Molecular Features of Malignant Bone Tumours Arising in the Craniofacial Skeleton
    Simon Haefliger, Vanghelita Andrei, Daniel Baumhoer · 2022 · Frontiers in Oncology
  14. Multi-modality management of chondrosarcoma of scapula: A case report and review of literature
    Ramakant Tiwari, Bharti Devnani, Balamurugan Thirunavukkarasu, Puneet Pareek, Prateek Daga, Amit Kumar · 2023 · Cancer Treatment and Research Communications
  15. Global research development of chondrosarcoma from 2003 to 2022: a bibliometric analysis
    Hansong Duan, Jiatong Li, Jianfei Ma, Ting Chen, He Zhang, Guanning Shang · 2024 · Frontiers in Pharmacology
  16. Molecular confirmation that fibrocartilaginous dysplasia is a variant of fibrous dysplasia
    Juan Zhou, Xuling Su, Dingjun Hu, Li Zhang, Chunyan Chen, Keyang Sun, Huizhen Zhang, Zhiyan Liu · 2024 · Journal of Clinical Pathology
  17. Femur chondrosarcoma misdiagnosed as acute knee arthritis and osteomyelitis—Further developing a hitherto unreported complication of tumor embolic ischemic ileal perforation after arthroscopic lavage
    Louis Tsun Cheung Chow · 2014 · Pathology - Research and Practice
  18. Fighting Fire with Fire in Cancer
    Thorsten Berger, Mary E. Saunders, Tak W. Mak · 2015 · Springer eBooks
  19. Structural basis for multi-specific peptide recognition by the anti-IDH1/2 monoclonal antibody, MsMab-1
    Yu Kitago, Mika Kato Kaneko, Satoshi Ogasawara, Yukinari Kato, Junichi Takagi · 2016 · Biochemical and Biophysical Research Communications
  20. Co-existence of lung carcinoma metastasis and enchondroma in the femur of a patient with Ollier disease
    Xudong Wang, Xiaohui Zhang, Wen-ling Pan, Yuedong Han, Yanwei Li, Haibin Sun, Pancras C.W. Hogendoorn, Hong Cheng · 2020 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  21. Intra-Articular Tumors
    Marta Sbaraglia, Marco Gambarotti, Gianluca Businello, Alberto Righi, Matteo Fassan, Angelo Paolo Dei Tos · 2021 · Surgical pathology clinics
  22. (B)On(e)-cohistones and the epigenetic alterations at the root of bone cancer
    Paolo Salomoni, Adrienne Margaret Flanagan, Lucia Cottone · 2023 · Cell Death and Differentiation
  23. Altered Expression of Oxidative Metabolism Related Genes in Cholangiocarcinomas
    Ratchadawan Aukkanimart, Thidarut Boonmars, Amornrat Juasook, Pranee Sriraj, Sirintip Boonjaraspinyo, Zhiliang Wu, Porntip Laummuanwai, Chawalit Pairojkul, Narong Khuntikeo, Panaratana Ratanasuwan · 2015 · Asian Pacific Journal of Cancer Prevention
  24. Neoplastic and tumor-like lesions of bone
    Yaxia Zhang, Andrew Eric Rosenberg, Lester James Layfield, G. Petur Nielsen · 2015 · Cambridge University Press eBooks
  25. Autophagic signaling promotes systems-wide remodeling in skeletal muscle upon oncometabolic stress
    Anja Karlstaedt, Heidi Vitrac, Rebecca Salazar, Benjamin D. Gould, Daniel Soedkamp, Weston R. Spivia, Koen Raedschelders, An Q Dinh, Anna G. Guzman, Lin Tan et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  26. A Genetic Model for Central Chondrosarcoma Evolution Correlates with Patient Outcome
    William C. H. Cross, Iben Lyskjær, Tom Lesluyes, Steven Hargreaves, Anna‐Christina Strobl, Christopher Davies, Sara Waise, Shadi Hames-Fathi, Dahmane Oukrif, Hongtao Ye et al. · 2021 · medRxiv
  27. Metabolic permissiveness: how tissue context shapes cancer
    Chrysanthi Moschandrea, Christian Frezza · 2026 · Genes & Development
  28. Mitochondrial Metabolomics in Cancer: Mass Spectrometry-Based Approaches for Metabolic Rewiring Analysis and Therapeutic Discovery
    Yuqing Gao, Zhirou Xiong, Xinyi Wei · 2025 · Metabolites
  29. Tumors of the Synovium
    Yee Lin Tang, Jad S. Husseini, G. Petur Nielsen · 2025 · Modern Pathology
  30. Isocitrate Dehydrogenase Mutations in Cancer: From Bench to Bedside Applications
    Yuhan Fang, Xiaoqing Wang, Kai Luo, Tikam Chand Dakal, He Bai, Caiming Xu, Guixin Zhang · 2026 · MedComm
  31. Updates in non-neoplastic orthopaedic pathology: what you don’t know can hurt you!
    Nooshin Karamzadeh Dashti, John David Reith, Scott Ethan Kilpatrick · 2024 · Journal of Clinical Pathology
  32. Glioblastoma
    Elizabeth Anne Maher, Robert M. Bachoo · 2024 · Elsevier eBooks
  33. Prevalence of SPOP and IDH Gene Mutations in Prostate Cancer in a Jordanian Population
    Mohammed Sayel Alorjani, Samir M. Al Bashir, Basmah Al-Zaareer, Sohaib Al-Khatib, Raed M. Al‐Zoubi, Bahaa Al‐Trad, Manal Issam Abu Alarjah, Ayman Alzu’bi, Mohammad Al-Hamad, Khalid Al‐Batayneh et al. · 2024 · Biochemical Genetics
  34. Targeting IDH1 mutation-driven Nrf2 signaling to suppress malignant behavior in fibrosarcoma cells
    Seoyeon Park, Kyung‐Soo Chun, Do‐Hee Kim · 2025 · Toxicological Research
  35. Predicting survival outcomes in dedifferentiated chondrosarcoma: a prognostic factor analysis from a National Registry
    Tomoya Masunaga, Shinji Tsukamoto, Kanya Honoki, Hiromasa Fujii, Akira Kido, Manabu Akahane, Yasuhito Tanaka, Andreas F. Mavrogenis, Costantino Errani, Akira Kawai · 2025 · SICOT-J
  36. Protein Phosphatase 1 Regulatory Subunit 3C integrates cholesterol metabolism and isocitrate dehydrogenase in chondrocytes and neoplasia
    Makoto Nakagawa, Eijiro Shimada, Nicholas J. Guardino, Ryo Miyamoto, Vijitha Puviindran, Emily M. Peairs, Ariana Matarangas, Koji Ishikawa, Tuyet Nguyen, MaKenna R. Browne et al. · 2025 · Proceedings of the National Academy of Sciences
  37. Vermeidung von Pitfalls in der Knochentumordiagnostik
    Mathias Werner · 2014 · Der Pathologe
  38. Clinical Applications of Molecular Markers in Bone Tumors
    Meera Hameed · 2015 · Advances in Anatomic Pathology
  39. Deep sequencing of a recurrent oligodendroglioma and the derived xenografts reveals new insights into the evolution of human oligodendroglioma and candidate driver genes
    Nadin D. Exner, Jaime Alberto Campos Valenzuela, Khalil Abou‐El‐Ardat, Hrvoje Miletić, Peter Csaba Huszthy, Petra M. Radehaus, Evelin Schröck, Rolf Bjerkvig, Lars Kaderali, Barbara Klink et al. · 2019 · Oncotarget
  40. Chondromesenchymal hamartomas in a 24-year-old male mimicking a posterior mediastinal tumor and a 5-month-old boy with postoperative disseminated intravascular coagulation: two case reports
    Yue Li, Danyang Zheng, Min Zuo, Yang Li, Huizhong Zhang · 2020 · Diagnostic Pathology
  41. Transcriptome Analysis of Ivosidenib-Mediated Inhibitory Functions on Non-Small Cell Lung Cancer
    Juan Wu, Ru Chen, Huiqing Shen, Ting Yan, Yu Qian, Ya‐Ping Zhang, Zhuoya Huang, Pengzhou Kong, Min Pang, Xinri Zhang · 2021 · Frontiers in Oncology
  42. Periosteal chondroma of rib at adulthood
    Can Berk Kurt, Tibet Uğur Kurak, Hamide Sayar, Fadime Eda Gökalp Satıcı, Erhan Ayan · 2021 · Current Thoracic Surgery
  43. An Integrated Immune-Related Bioinformatics Analysis in Glioma: Prognostic Signature’s Identification and Multi-Omics Mechanisms’ Exploration
    Xin Fan, Lingling Zhang, Junwen Huang, Yun Zhong, Yanting Fan, Tong Zhou, Min Lu · 2022 · Frontiers in Genetics
  44. Cancer metabolism regulation by phytonutrients
    Ammara Riaz, Rabia Zara, Gul Bushra, Nazia Kanwal, Ayesha Sadiqa, Farzana Shareef, Iqra Sarfraz, Muhammad Ajmal Shah, İlknur Uçak, Shazia Anwer Bukhari et al. · 2022 · Elsevier eBooks
  45. Targeting epigenetic aberrations of sarcoma in CRISPR era
    Miwa Tanaka, Takuro Nakamura · 2023 · Genes Chromosomes and Cancer
  46. An on-line heart-cutting two-dimensional liquid chromatography method for intracellular 2-hydroxyglutarate enantiomers
    Takuma Ohtawa, Makoto Tsunoda · 2023 · Analytical Methods
  47. Actualización de los tumores cartilaginosos según la clasificación de la OMS de 2020
    S. Gómez-Peña, Alexandro Eusebio, Juan Arrazola García, P. Romero Fernández, M.J. Moreno Casado, Ana María Crespo Rodríguez · 2023 · Radiología
  48. IDH1‐mutated Crohn's disease‐associated small bowel adenocarcinomas: Distinctive pathological features and association with MGMT methylation and serrated‐type dysplasia
    Camilla Guerini, Daniela Furlan, Giuseppina Ferrario, Federica Grillo, Laura Libera, Giovanni Arpa, Catherine Klersy, Marco Vincenzo Lenti, Roberta Riboni, Enrico Solcia et al. · 2023 · Histopathology
  49. The Leukemic Isocitrate Dehydrogenase (IDH) 1/2 Mutations Impair Myeloid and Erythroid Cell Differentiation of Primary Human Hematopoietic Stem and Progenitor Cells (HSPCs)
    Sara Pierangeli, Serena Donnini, Valerio Ciaurro, Francesca Milano, Valeria Cardinali, Sofia Sciabolacci, Gaetano Cimino, Ilaria Gionfriddo, Roberta Ranieri, Sabrina Cipriani et al. · 2024 · Cancers
  50. Preparation and Preclinical Evaluation of 18F-Labeled Olutasidenib Derivatives for Non-Invasive Detection of Mutated Isocitrate Dehydrogenase 1 (mIDH1)
    Roberta Cologni, Marcus H. Holschbach, Daniela Schneider, Dirk DB Bier, Annette Schulze, Carina Stegmayr, Heike Endepols, Johannes Ermert, Felix Neumaier, Bernd Neumaier · 2024 · Molecules
  51. Metachondromatosis without Enchondromas
    Kohei Kanaya, Aki Ishikawa, Masako Yaoita, Tetsuya Niihori, Yoko Aoki, Kousuke Iba, Toshihiko Yamashita · 2016 · JBJS Case Connector
  52. Ivosidenib for the treatment of relapsed or refractory acute myeloid leukemia with an IDH1 mutation
    Florence Pasquier, Claude Chahine, Christophe Marzac, Stéphane de Botton · 2020 · Expert Review of Precision Medicine and Drug Development
  53. Histopathology of Adult and Pediatric Glioblastoma
    Appaji Rayi, Peter J. Kobalka · 2021 · Molecular pathology library
  54. The clinical impact of molecular techniques on diagnostic pathology of soft tissue and bone tumours
    Salvatore Osvaldo Romeo, Angelo Paolo Dei Tos, Pancras C.W. Hogendoorn · 2011 · Diagnostic histopathology
  55. Similar cytogenetic findings in two synchronous secondary peripheral chondrosarcomas in a patient with multiple osteochondromas
    Anastasios I. Kyriazoglou, Efthimios Dimitriadis, Niki Arnogiannaki, Petter Brandal, Sverre Heim, Nikos Pandis · 2011 · Cancer Genetics
  56. Targeted Therapy in Sarcoma: Should We Be Lumpers or Splitters?
    Richard F. Riedel, Robert G. Maki, Andrew J. Wagner · 2012 · American Society of Clinical Oncology Educational Book
  57. Markers for bone sarcomas
    Gonzague Du Bouexic De Pinieux, Anne Gomez‐Brouchet, Corinne Bouvier · 2014 · Elsevier eBooks
  58. Molecular Markers in Bone and Soft-Tissue Tumors
    Rosanna L. Wustrack, Kumarasen Cooper, KRISTY L. WEBER · 2016 · JBJS Reviews
  59. Dedifferentiated Chondrosarcoma
    G. Petur Nielsen, Andrew Eric Rosenberg, Vikram Deshpande, Francis John Hornicek, Susan V. Kattapuram, Daniel I. Rosenthal · 2017 · Elsevier eBooks
  60. Conventional Central Osteosarcoma
    Franco Bertoni, Patrizia Bacchini · 2015 · Springer eBooks
  61. Inactivation of Lkb1 in postnatal chondrocytes leads to epiphyseal growth‐plate abnormalities and promotes enchondroma‐like formation
    Sheng Zhou, Yixuan Li, Liang Qiao, Yuxiang Ge, Xiaojing Huang, Xiang Gao, Huangxian Ju, Wei J. Wang, Junfeng Zhang, Jun Yan et al. · 2019 · The FASEB Journal
  62. The Epidemiology and Pathogenesis of Sarcoma
    Wassif Kabir, Peter Choong · 2020 · Springer eBooks
  63. Molecular Genetics of Multiple Osteochondromas
    Carlos E. de Andrea, Pancras C.W. Hogendoorn, Judith V.M.G. Bovée · 2016 · Encyclopedia of Life Sciences
  64. First Report of NSCLC With IDH1 Mutation: A Case Report
    Yuyue Zhang, Yanmei Liu, Ganghui Ye, Yan Ding, Shixiu Wu, Shenpeng Ying · 2025 · Clinical Lung Cancer
  65. Advances in IDH-mutant glioma management: IDH inhibitors, clinical implications of INDIGO trial, and future perspectives
    Christianne V. Mojica, Katrina Mari E. Gutierrez, Warren P. Mason · 2025 · Future Oncology
  66. Scaffold modification and synthesis routes for targeting mutant IDH 1: a review
    Vasavi S. Pai, Namit Kumar · 2025 · Discover Applied Sciences
  67. Tall cell carcinoma with reversed polarity of the breast harbouring IDH1 hotspot mutation: morphologic, immunohistochemical and genetic characterization of two cases
    Gregor Krings, Sherin I. Hashem, Marsha A Apushkin, Tina L Ang‐Rabanes, Raza S. Hoda · 2025 · Histopathology
  68. Clinical advancement in the management of mutant isocitrate dehydrogenase (IDH) cancers
    John A. Bridgewater, Ghazaleh Tabatabai, Teresa Mercade Macarulla, Silvia Stacchiotti · 2026 · European Journal of Cancer Supplements
  69. MiRNA-based expression signatures in differential diagnosis of enchondroma and chondrosarcoma
    Annabell Walter, Kathrin Katenkamp, Nikolaus Gaßler, Thomas Lehmann, Wolfram Weschenfelder, Christian Spiegel, Gunther Olaf Hofmann, Amer Malouhi, Andreas Hochhaus, Jenny Rinke et al. · 2026 · Journal of bone oncology
  70. Chondrosarcoma: A comprehensive review of tumor biology, clinical behavior, and therapeutic advances
    Luyuan Li, Genevieve Bertolet, Josiane E. Eid, William D. Tap, Andrew J. Wagner, Anthony Paul Conley, Francis John Hornicek, Zhenfeng Duan, Emanuela Palmerini, Jonathan C. Trent · 2026 · Cancer Treatment Reviews
  71. HOT mutation screening in human glioblastomas
    Daniel Krell, Paul James Mulholland, Justin Stebbing, Ian P.M. Tomlinson, Chiara Bardella · 2015 · Future Science OA
  72. A Case of Metastatic Biliary Tract Cancer Diagnosed Through Identification of an IDH1 Mutation
    Suneel Deepak Kamath, Xiaoqi Lin, Aparna Kalyan · 2018 · The Oncologist
  73. Cancer of Bones and Joints
    Pancras C.W. Hogendoorn, Carlos E. de Andrea · 2018 · Elsevier eBooks
  74. IDH -wildtype secondary glioblastoma arising in IDH -mutant diffuse astrocytoma: a case report
    Byul-Hee Yoon, Ju Sang Park, Seong-Min Kang, Nak‐Jung Kwon, Kyu Sang Lee, Chae‐Yong Kim, Gheeyoung Choe · 2020 · British Journal of Neurosurgery
  75. Pathology of Chondrosarcoma
    Muhammad Omar Hakim, Andrew Eric Rosenberg · 2021 · Springer eBooks
  76. Status of IDH mutations in chondrosarcoma of the jaws
    Z. You, J. Zhang, Hong‐Tu Zhang, X. Li, Zhipeng Sun, Li Sun · 2022 · International Journal of Oral and Maxillofacial Surgery
  77. A big picture of the mitochondria-mediated signals: From mitochondria to organism
    Neşe Vardar Acar, Rıza Köksal Özgül · 2023 · Biochemical and Biophysical Research Communications
  78. Hunting for the vulnerability in chondrosarcoma by tracing metabolic and genetic links
    Yi‐Jun Kim, Hyun Guy Kang, Jin‐Hong Kim · 2024 · Cell Reports Medicine
  79. SMARCB1-Deficient Skull Base Chondrosarcoma with 12p Duplication Presenting as Somatic-Type Malignancy Arising from Metastatic Seminoma
    Prokopios P. Argyris, Bindu S. Challa, Swati P. Satturwar, Kyle K. VanKoevering, Paul E. Wakely · 2024 · Head and Neck Pathology
  80. Ollier Disease, Acute Myeloid Leukemia, and Brain Glioma: IDH as the Common Denominator
    Sergio Corvino, Teresa Somma, Francesco Certo, Giulio Bonomo, Erica Grasso, Felice Esposito, Jacopo Berardinelli, Giuseppe Maria Vincenzo Barbagallo · 2024 · Cancers
  81. Molecular insights and functional analysis of isocitrate dehydrogenase in two gram-negative pathogenic bacteria
    Wei Xiong, Rui Su, Xueyang Han, Mengxiao Zhu, H Tang, Shiping Huang, Peng Wang, Guoping Zhu · 2024 · World Journal of Microbiology and Biotechnology
  82. Mesenchymal Chondrosarcoma of the Mandible, a Big Dilemma: Report of a Rare Case in Mesenchymal Chondrosarcoma of the Mandible—Report of a Case With Discussion of Diagnostic and Therapeutic Dilemmas
    Abbas Karimi, Samira Derakhshan, Farzaneh Mosavat, Zahra Gholamhoseini, Monir Moradzadeh Khiavi · 2024 · Case Reports in Dentistry
  83. A Rare Entity of the Anterior Chest Cage Rib Chondrosarcoma: A Case Report and Review of Literature
    Majed Al-Mourgi, Anwar M. Shams · 2024 · Seminars in Thoracic and Cardiovascular Surgery
  84. Research trends and foci in chondrosarcoma: A bibliometric and network analysis
    Yuming Yao, Ruhao Zhou, Guang Yang, Bingzhou Ji, Yusheng Li, Jun Zhang · 2024 · Medicine
  85. Liquid Biopsy for Spinal Tumors: On the Frontiers of Clinical Application
    Sze Kiat Tan, Chetan Bettegowda, Stephen Yip, Arjun Sahgal, Laurence D. Rhines, Jeremy J. Reynolds, Áron Lazáry, Ilya Laufer, Alessandro Gasbarrini, Nicolas Dea et al. · 2025 · Global Spine Journal
  86. Application of patient derived xenograft model in personalized drug screening for chondrosarcoma of head and neck: A preclinical study
    Yufei Hua, Zhiyong Guo, Ying Wang, Chunjie Li, Bing Yan · 2025 · Oral Oncology
  87. Vermeidung von Pitfalls in der Knochentumordiagnostik aus der Sicht des Pathologen
    Mathias Werner · 2016 · Der Radiologe
  88. Telomere Maintenance Mechanisms: Prognostic and Therapeutic Implications for the Pathologist and Oncologist
    Noelyn Anne Hung, Howard Hsia, Janice A. Royds, Tania L. Slatter · 2013 · Open Journal of Pathology
  89. Cancer 2015: a longitudinal whole-of-system study of genomic cancer medicine
    David Morgan Thomas, Stephen B. Fox, Paula Kate Lorgelly, David M. Ashley, Gary Edward Richardson, Lara Rachel Lipton, John P. Parisot, Mark Lucas, John J. McNeil · 2015 · Drug Discovery Today
  90. Molecular Characterization of Bone Tumors and Implications for Treatment and Prognosis
    Michael J. Monument, Kevin B. Jones · 2014 · Journal of the National Comprehensive Cancer Network
  91. PET/CT Helps Downgrade an Aggressive-Appearing Rib Mass to a Probable Benign Lesion in a 9-Year-Old Girl
    Kimeya F. Ghaderi, Don C. Yoo, Jesse L. Hart · 2015 · Clinical Nuclear Medicine
  92. Accuracy of 1H magnetic resonance spectroscopy for quantification of 2-hydroxyglutarate using linear combination and J-difference editing at 9.4 T
    Ulf Neuberger, Philipp Kickingereder, Xavier Helluy, Manuel Dominik Fischer, Martin Bendszus, Sabine Heiland · 2017 · Zeitschrift für Medizinische Physik
  93. Molecular Diagnostics in Bone and Soft Tissue Tumors
    Vickie Y. Jo, Xiaohua Qian · 2018 · Springer eBooks
  94. Clear Cell Chondrosarcoma with Rib Cage Metastasis: Case Report
    Rui Caetano Oliveira, John David Reith, José Casanova · 2021 · Case Reports in Oncology
  95. Biology of cartilage tumor family
    Laura S. Hiemcke‐Jiwa, Judith V.M.G. Bovée · 2021 · Elsevier eBooks
  96. Enchondroma in the Diaphysis of Tibia – A Case Report and Review of its Characteristics and Differentials in the Diaphysis
    Keerthan Ranga Nayak U, Sharath Kumar Rao, Sharath Kumar Rao, Sharath Kumar Rao · 2021 · Journal of Orthopaedic Case Reports
  97. Applications of Molecular Testing to Differential Diagnosis
    Wei‐Lien Wang, Alexander J. Lazar · 2019 · Elsevier eBooks
  98. Chondrosarcoma of the toe: A case report and literature review
    Li-Bo Zhou, He-Cheng Zhang, Zai-Gang Dong, Chaochao Wang · 2022 · World Journal of Clinical Cases
  99. A Rare Co-Occurrence of Maffucci Syndrome and Astrocytoma with IDH1 R132H Mutation: A Case Report
    Nurali Ashirov, Iroda Zukhritdinkyzy Mammadinova, Aidos Moldabekov, Б Б Жетписбаев, Daniyar Teltayev, Nurzhan Ryskeldiyev, Serik Akshulakov · 2023 · Medicina
  100. Neue molekulare Aspekte der Chordome
    Stefanie Scheil-Bertram · 2014 · Der Pathologe